Clinically, mutation carriers are characterized by severe obesity, severe hyperinsulinemia, increased lean body mass, and linear growth, whereas MC4R homozygous patients—although rarely identified—are more severely affected [45]. This evidence concerns the gene MC4R and obesity disorder.